Press Release

The Competition Commission, in its meeting on 26.04.2023, reviewed three concentration notices related to the international market:

  1. The concentration obtained through the acquisition of control over METRO FARMACI LLC by DELTA HOLDING LLC.
  2. The concentration obtained through the acquisition of control over AVICENA LLC by DELTA HOLDING LLC.
  3. The concentration obtained through the acquisition of control over DELTA PHARMA-AL LLC by DELTA HOLDING LLC.

After careful consideration, it was determined that these announced concentrations do not create any overlaps or upstream/downstream relationships between the activities of the parties involved at the national level. Therefore, they will not bring about any changes or have any impact on the Albanian market.

Based on these findings, the Competition Commission, by Decision no. 977 dated 26.04.2023, authorized the concentration obtained through the acquisition of control over METRO FARMACI SHPK by DELTA HOLDING SHPK; by Decision No. 978 dated 26.04.2023, authorized the concentration obtained through the acquisition of control over AVICENA LLC by DELTA HOLDING LLC; by Decision No. 979 dated 26.04.2023 authorized the concentration obtained through the acquisition of control over DELTA PHARMA-AL LLC by DELTA HOLDING LLC.

For more information, please refer to the official website of the Albanian Competition Authority at https://caa.gov.al .

Dërgoni Ankesën Tuaj

    Mund të ngarkohen një ose më shumë dokumenta, në formatet: Word, Excel,Jpeg dhe PDF

    Të dhënat tuaja do të trajtohen me konfidencialitet të plotë sipas ligjit nr.9887, datë 10.03.2008, 'Për mbrojtjen e të dhënave personale', i ndryshuar.